Latest news with #AlignTechnology
Yahoo
19 hours ago
- Business
- Yahoo
Align Technology, Inc. (ALGN): A Bull Case Theory
We came across a bullish thesis on Align Technology, Inc. (ALGN) on DIY Investor's Substack. In this article, we will summarize the bulls' thesis on ALGN. Align Technology, Inc. (ALGN)'s share was trading at $188.07 as of 10th June. ALGN's trailing and forward P/E were 32.9 and 17.7 respectively according to Yahoo Finance. A patient's smile enhanced by a dental technology device. Align Technology (ALGN), the maker of Invisalign and leader in clear aligners with over 90% market share, offers a compelling, if measured, investment case. Historically, ALGN traded at high valuations—around 32x P/E during its growth phase and peaking at 80x in 2018—reflecting both its strong brand moat and investor enthusiasm. However, despite doubling its earnings since then, the stock has corrected sharply due to overvaluation, trading now at 18x P/E with consensus expecting ~10% annual EPS growth over the next three years. Using a conservative fair value estimate of $200 based on a 10.8 EPS average and historical valuation norms, the stock appears to offer a ~20% discount from current levels near $180, suggesting ~10% annual returns if the multiple remains steady. Importantly, Align has a strong track record of meeting or beating analyst expectations, lending confidence to forward projections. Morningstar supports the undervaluation thesis, assigning a fair value of $240 and a narrow moat rating, though they acknowledge macro and competitive risks. Align's moat stems from intangible assets like SmartTrack materials and 25 years of clinical data, high switching costs for doctors, and some indirect network effects. Though it lacks a cost advantage or natural scale barriers, its capital allocation is sound: debt-light, R&D-focused, and growth-oriented. Strategic acquisitions like Exocad complement its innovation roadmap, while minimal buybacks and no dividends reflect a long-term growth posture. Overall, Align represents a high-quality business trading at a fair price, with moderate upside for investors comfortable with industry cyclicality and valuation-driven risk. Previously, we covered a bullish thesis on Procter & Gamble (PG) by Librarian Capital, emphasizing its brand dominance, resilient cash flows, and appeal as a defensive compounder amid consumer headwinds. DIY Investor's thesis on Align Technology (ALGN) contrasts this with a growth-oriented case, highlighting Invisalign's moat, earnings momentum, and undervaluation after a sharp multiple compression. Align Technology, Inc. (ALGN) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 52 hedge fund portfolios held ALGN at the end of the first quarter which was 58 in the previous quarter. While we acknowledge the risk and potential of ALGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 hours ago
- Business
- Yahoo
Align Technology, Inc. (ALGN): A Bull Case Theory
We came across a bullish thesis on Align Technology, Inc. (ALGN) on DIY Investor's Substack. In this article, we will summarize the bulls' thesis on ALGN. Align Technology, Inc. (ALGN)'s share was trading at $188.07 as of 10th June. ALGN's trailing and forward P/E were 32.9 and 17.7 respectively according to Yahoo Finance. A patient's smile enhanced by a dental technology device. Align Technology (ALGN), the maker of Invisalign and leader in clear aligners with over 90% market share, offers a compelling, if measured, investment case. Historically, ALGN traded at high valuations—around 32x P/E during its growth phase and peaking at 80x in 2018—reflecting both its strong brand moat and investor enthusiasm. However, despite doubling its earnings since then, the stock has corrected sharply due to overvaluation, trading now at 18x P/E with consensus expecting ~10% annual EPS growth over the next three years. Using a conservative fair value estimate of $200 based on a 10.8 EPS average and historical valuation norms, the stock appears to offer a ~20% discount from current levels near $180, suggesting ~10% annual returns if the multiple remains steady. Importantly, Align has a strong track record of meeting or beating analyst expectations, lending confidence to forward projections. Morningstar supports the undervaluation thesis, assigning a fair value of $240 and a narrow moat rating, though they acknowledge macro and competitive risks. Align's moat stems from intangible assets like SmartTrack materials and 25 years of clinical data, high switching costs for doctors, and some indirect network effects. Though it lacks a cost advantage or natural scale barriers, its capital allocation is sound: debt-light, R&D-focused, and growth-oriented. Strategic acquisitions like Exocad complement its innovation roadmap, while minimal buybacks and no dividends reflect a long-term growth posture. Overall, Align represents a high-quality business trading at a fair price, with moderate upside for investors comfortable with industry cyclicality and valuation-driven risk. Previously, we covered a bullish thesis on Procter & Gamble (PG) by Librarian Capital, emphasizing its brand dominance, resilient cash flows, and appeal as a defensive compounder amid consumer headwinds. DIY Investor's thesis on Align Technology (ALGN) contrasts this with a growth-oriented case, highlighting Invisalign's moat, earnings momentum, and undervaluation after a sharp multiple compression. Align Technology, Inc. (ALGN) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 52 hedge fund portfolios held ALGN at the end of the first quarter which was 58 in the previous quarter. While we acknowledge the risk and potential of ALGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Yahoo
3 days ago
- Business
- Yahoo
Align Technology Stock: Is ALGN Underperforming the Healthcare Sector?
With a market cap of $12.7 billion, Tempe, Arizona-based Align Technology, Inc. (ALGN) designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States and internationally. Companies worth $10 billion or more are generally described as "large-cap stocks." ALGN falls squarely into this category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. ALGN offers CAD/CAM digital services used in dentistry, orthodontics, and dental records storage through its two operating segments, Clear Aligner and CAD/CAM Services. Is Palantir Stock Poised to Surge Amidst the Israel-Iran Conflict? 'It Has No Utility': Warren Buffett Doesn't Care How High Gold Goes, He Isn't a Buyer OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Shares of ALGN touched their 52-week high of $263.24 on Jul. 18, 2024, and have fallen 31.6% from that peak. They have grown 9.4% over the past three months, outperforming the Health Care Select Sector SPDR Fund's (XLV) 9.3% fall over the same time frame. Shares of the company have declined 25.7% over the past 52 weeks, compared to XLV's 8.7% fall over the same time frame. Moreover, ALGN stock is down 13.7% on a YTD basis, underperforming XLV's 3.2% fall. ALGN shares have been trading below their 200-day moving average for the past year and mostly above their 50-day moving average since late April. On Apr. 30, ALGN shares declined 2.5% following the release of its Q1 results. The company's revenue came in at $979.3 million, beating Wall Street forecasts of $972.8 million. Its adjusted EPS of $1.52 surpassed Wall Street expectations marginally. ALGN expects revenue in the range of $1.05 billion to $1.07 billion for Q2. Its peer, Solventum Corporation (SOLV), has surged 10% in 2025 and 36.2% over the past year, outperforming the stock. Among the 13 analysts covering the ALGN stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $234.25 suggests a 30.1% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Associated Press
4 days ago
- Business
- Associated Press
Align Technology Launches Integrated Consumer and Professional Brand Campaign Focused on Invisalign® Treatment for Kids and Teens
TEMPE, Ariz.--(BUSINESS WIRE)--Jun 17, 2025-- Align Technology, Inc. ('Align') (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced integrated global professional and consumer campaigns to highlight the unique needs of growing patients and treatment options for meeting those needs and creating new smiles with the Invisalign clear aligner system. This press release features multimedia. View the full release here: New 'Invisalign for Kids' brand consumer campaign educates parents of younger children about the benefits of Invisalign® clear aligners. 'We are proud to launch these complementary Invisalign ® brand campaigns about the kid and teen-friendly orthodontic solutions from the #1 doctor-recommended clear aligner brand, 1 ' said Kamal Bhandal, senior vice president, Global Brand, Consumer and Americas Marketing. 'Our new 'Invisalign for Kids' brand consumer campaign is designed to increase awareness with parents that Invisalign aligners are an effective solution for kids and educate parents about the benefits of Invisalign treatment for kids and teens, including Invisalign ® Palatal Expander System, Invisalign First™, Invisalign ® System with mandibular advancement, as well as Invisalign ® Virtual Care to help parents monitor progress – all designed to deliver predictable results and a positive experience for growing children.' The aspects of Invisalign treatment, from Phase 1 to comprehensive Phase 2, to retention are designed for predictable results and a positive experience while addressing the unique needs of growing children. And with Invisalign aligners, children can enjoy their favorite foods, keep up their oral hygiene, maintain an active lifestyle, and smile and build their confidence. At the same time, our companion Invisalign 'Growing Patients' professional campaign provides doctors with information and awareness about the dedicated range of Invisalign treatment options designed specifically for children and teens from well-established products such as Invisalign First™ aligners to the latest additions in the growing patient product portfolio, including the Invisalign ® Palatal Expander System and Invisalign ® System with mandibular advancement featuring occlusal blocks ('MAOB'). Doctors can use the Invisalign System to treat nearly any orthodontic case, from children through teens to adults, at the different stages of their growth. Even with some baby teeth, it may be the perfect time for children ages 6 to 10 to start Phase 1 orthodontic treatment. According to the American Association of Orthodontists ('AAO'), children should get screened by an orthodontist by age 7. 2 Phase 1 treatment takes advantage of a child's normal development to help bones in the face and mouth grow correctly and reduce the need for more extensive treatment later. Once most permanent teeth are in place, Phase 2 treatment focuses on ensuring teeth are in their proper place for a healthy bite and a pleasing appearance. 3 'As kids and teens age and grow, orthodontic treatment needs to address both tooth movement and dental facial orthopedic or skeletal movement,' said Dr. Mitra Derakhshan, executive vice president, chief clinical officer, Global Treatment Planning and Clinical Services. 'As the leader in digital orthodontics, Align has developed an extensive end-to-end portfolio that helps doctors treat a range of case types including the most complex cases, and growing patients and kids as young as 6. I believe our new 'Invisalign for Kids' brand and 'Growing Patients' campaigns will help increase confidence in Invisalign treatment for the largest segment of the orthodontic market and drive further adoption among growing patients.' This latest announcement is part of Align's long-term investment in the growing patients' segment of the market which has included multiple innovation milestones over 20 million smiles. Overview of Invisalign products for growing patients: 'Our commitment is to support our doctors in treating patients through every step of their journey – from first visit to a lasting smile. More than 28 years of anonymized data from more than 20 million Invisalign ® patients treated globally have helped Align develop our integrated suite of innovative products and solutions that enable doctors to treat patients over their continuum of care,' said Michael Smith, Align vice president, Product Management. 'This new integrated campaign highlights the unique product offerings within our growing patient portfolio and how we are innovating in digital orthodontics to empower doctors to transform smiles and change lives.' 1. Based on a global survey of 1,786 doctors (dentists and orthodontists who use clear aligners) by IQVIA in NA, EMEA, LATAM, and APAC. Data on File at Align Technology, as of June 30, 2022. 2. American Academy of Orthodontists. The Right Time: When Should Your Child See an Orthodontist? ( ) Accessed 2/26/24. 3. American Academy of Orthodontists. Embarking on a Two Phase Orthodontic Adventure ( ) Accessed 2/28/24. 4. Based on a survey in August 2023 in Canada of 10 Invisalign trained orthodontists who participated in the Invisalign Palatal Expander System Technical Design Assessment and have treated at least 1 patient age 6-11 years with IPE. Data on file at Align Technology, Inc. as of October 30, 2023. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc. View source version on CONTACT: Align Technology Madelyn Valente (909) 833-5839 [email protected] Group Sarah Karlson (828) 551-4201 [email protected] KEYWORD: UNITED STATES NORTH AMERICA ARIZONA INDUSTRY KEYWORD: TECHNOLOGY TEENS MEDICAL DEVICES CHILDREN DENTAL HEALTH TECHNOLOGY SOFTWARE HEALTH CONSUMER SOURCE: Align Technology, Inc. Copyright Business Wire 2025. PUB: 06/17/2025 07:06 PM/DISC: 06/17/2025 07:06 PM
Yahoo
4 days ago
- Business
- Yahoo
Align Technology Launches Integrated Consumer and Professional Brand Campaign Focused on Invisalign® Treatment for Kids and Teens
New "Invisalign for Kids" brand consumer campaign educates parents of younger children about the benefits of Invisalign® clear aligners New Kids and Teens Invisalign "Growing Patients" professional campaign supports doctors with information including a full range of dedicated products, tools, and treatment options across the Invisalign portfolio that explains how Invisalign treatment specifically meets the needs of growing patients at the stages of their development New campaigns are part of Align's year-long 20 million smilestone celebration, and feature Invisalign innovation helping doctors transform over 5.8 million kids, teens, and growing patient smiles TEMPE, Ariz., June 17, 2025--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced integrated global professional and consumer campaigns to highlight the unique needs of growing patients and treatment options for meeting those needs and creating new smiles with the Invisalign clear aligner system. "We are proud to launch these complementary Invisalign® brand campaigns about the kid and teen-friendly orthodontic solutions from the #1 doctor-recommended clear aligner brand,1" said Kamal Bhandal, senior vice president, Global Brand, Consumer and Americas Marketing. "Our new "Invisalign for Kids" brand consumer campaign is designed to increase awareness with parents that Invisalign aligners are an effective solution for kids and educate parents about the benefits of Invisalign treatment for kids and teens, including Invisalign® Palatal Expander System, Invisalign First™, Invisalign® System with mandibular advancement, as well as Invisalign® Virtual Care to help parents monitor progress – all designed to deliver predictable results and a positive experience for growing children." The aspects of Invisalign treatment, from Phase 1 to comprehensive Phase 2, to retention are designed for predictable results and a positive experience while addressing the unique needs of growing children. And with Invisalign aligners, children can enjoy their favorite foods, keep up their oral hygiene, maintain an active lifestyle, and smile and build their confidence. At the same time, our companion Invisalign "Growing Patients" professional campaign provides doctors with information and awareness about the dedicated range of Invisalign treatment options designed specifically for children and teens from well-established products such as Invisalign First™ aligners to the latest additions in the growing patient product portfolio, including the Invisalign® Palatal Expander System and Invisalign® System with mandibular advancement featuring occlusal blocks ("MAOB"). Doctors can use the Invisalign System to treat nearly any orthodontic case, from children through teens to adults, at the different stages of their growth. Even with some baby teeth, it may be the perfect time for children ages 6 to 10 to start Phase 1 orthodontic treatment. According to the American Association of Orthodontists ("AAO"), children should get screened by an orthodontist by age 7.2 Phase 1 treatment takes advantage of a child's normal development to help bones in the face and mouth grow correctly and reduce the need for more extensive treatment later. Once most permanent teeth are in place, Phase 2 treatment focuses on ensuring teeth are in their proper place for a healthy bite and a pleasing appearance.3 "As kids and teens age and grow, orthodontic treatment needs to address both tooth movement and dental facial orthopedic or skeletal movement," said Dr. Mitra Derakhshan, executive vice president, chief clinical officer, Global Treatment Planning and Clinical Services. "As the leader in digital orthodontics, Align has developed an extensive end-to-end portfolio that helps doctors treat a range of case types including the most complex cases, and growing patients and kids as young as 6. I believe our new "Invisalign for Kids" brand and "Growing Patients" campaigns will help increase confidence in Invisalign treatment for the largest segment of the orthodontic market and drive further adoption among growing patients." This latest announcement is part of Align's long-term investment in the growing patients' segment of the market which has included multiple innovation milestones over 20 million smiles. Overview of Invisalign products for growing patients: 2008: Invisalign® Teen – Teen specific features to address patient compliance, natural eruption of permanent teeth, and root-movement control – issues that are common in treatment of younger patients. 2017: Invisalign® System with mandibular advancement – the first clear aligner solution designed for simultaneous Class II correction and alignment in growing tween and teen patients and Invisalign® System with mandibular advancement featuring enhanced precision wings. 2018: Invisalign First™ – the first clear aligner treatment with features designed specifically to address a broad range of indications in mixed-dentition patients, including shorter clinical crowns, management of erupting dentition, and predictable dental arch expansion. 2023: Invisalign® Palatal Expander System –Align's first direct 3D printed orthodontic device, provides a safe, comfortable, and clinically effective4 alternative to traditional palatal expanders that require manually turning a screw in the device in the mouth daily to achieve skeletal expansion. 2025: Invisalign® System with mandibular advancement featuring occlusal blocks – Align's first clear aligner product with integrated solid occlusal blocks that delivers predictable mandibular advancement. Invisalign occlusal blocks provide durability, improve engagement, and enable vertical opening to offer earlier advancement of the mandible in cases like Class II deep bite to improve treatment efficiency. "Our commitment is to support our doctors in treating patients through every step of their journey – from first visit to a lasting smile. More than 28 years of anonymized data from more than 20 million Invisalign® patients treated globally have helped Align develop our integrated suite of innovative products and solutions that enable doctors to treat patients over their continuum of care," said Michael Smith, Align vice president, Product Management. "This new integrated campaign highlights the unique product offerings within our growing patient portfolio and how we are innovating in digital orthodontics to empower doctors to transform smiles and change lives." 1. Based on a global survey of 1,786 doctors (dentists and orthodontists who use clear aligners) by IQVIA in NA, EMEA, LATAM, and APAC. Data on File at Align Technology, as of June 30, 2022. 2. American Academy of Orthodontists. The Right Time: When Should Your Child See an Orthodontist? ( Accessed 2/26/24. 3. American Academy of Orthodontists. Embarking on a Two Phase Orthodontic Adventure ( Accessed 2/28/24. 4. Based on a survey in August 2023 in Canada of 10 Invisalign trained orthodontists who participated in the Invisalign Palatal Expander System Technical Design Assessment and have treated at least 1 patient age 6-11 years with IPE. Data on file at Align Technology, Inc. as of October 30, 2023. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc. View source version on Contacts Align Technology Madelyn Valente(909) 833-5839mvalente@ Zeno Group Sarah Karlson(828)
